Calico taps Mabwell’s anti-ageing antibody in $596m licensing deal
FierceBiotech - 26-Jul-2025Alphabet's Calico licenses IL-11 drug to target age-related diseases beyond China
Join the club for FREE to access the whole archive and other member benefits.
Track where the serious money is being invested in the longevity industry.
Alphabet's Calico licenses IL-11 drug to target age-related diseases beyond China
UK project aims to build human DNA from scratch, raising hopes for cures—and ethical concerns
Nomaly uses AI to decode disease from genomes, enabling precision medicine with small datasets
Tech screens 1,000s of antibodies per assay; links chronic inflammation to faster ageing
Click on resource name for more details.
30-Aug-2025
Opportunity to invest in longevity with investors, longevity entrepreneurs, scientists and policy makers (Aix-en-Provence, France)
11-Jun-2025
Summit exploring the Aging Code through AI organised by Longevity Global (Cambridge, MA, USA)
Venture capital fund that invests in life sciences, cancer research, age-related diseases and regenerative medicine
04-Apr-2025 to 25-May-2025
Ground-breaking longevity innovation zone set to transform the Bay Area into the global epicenter of human longevity innovation (Berkeley, CA)
27-Mar-2025
Exploring questions around society’s technological needs of the future with Innovate UK's event (London, UK)
26-Feb-2025
London Longevity online webinar with Professor Ronjon Nag
Great to see a startup willing to explicitly state they are treating ageing itself as a disease
Adrian reviews a range of finalists trying to track cancer, blood oxygenation, retinal scans, and cardiac health
Skincare product R&D budgets exceed the National Institute on Aging's budget - let's get it focussed on real anti-aging science